$70.53-0.22 (-0.32%)
News25/Ratings6
Price$70.53+39.62 (+128.20%)
2025-08-132025-11-13
News · 26 weeks390%
2025-11-022026-04-26
Mix090d
No activity.
Latest news
25 items- SECSEC Form 15-12G filed by Metsera Inc.15-12G - Metsera, Inc. (0002040807) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Metsera Inc.SCHEDULE 13G/A - Metsera, Inc. (0002040807) (Subject)
- INSIDERSee Remark 1 Fmr Llc disposed of 2,233,460 shares (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERDirector Arch Venture Partners Xii, Llc returned 26,816,808 shares to the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Metsera Inc.SCHEDULE 13D/A - Metsera, Inc. (0002040807) (Subject)
- SECSEC Form SCHEDULE 13G filed by Metsera Inc.SCHEDULE 13G - Metsera, Inc. (0002040807) (Subject)
- INSIDERCHIEF LEGAL OFFICER Lang Matthew returned 12,500 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERDirector Berns Paul L returned 16,798,952 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERCHIEF MEDICAL OFFICER Marso Steven returned 17,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERLarge owner Population Health Partners Gp, Llc returned 12,767,462 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERDirector Burow Kristina returned 51,414,082 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERLarge owner Validae Health, L.P. disposed of 12,767,462 shares, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERDirector Stonehouse Jon P returned 2,688 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERDirector Pinto Joshua returned 2,688 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERCHIEF SCIENTIFIC OFFICER Hubbard Brian returned 17,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDEROfficer Bernard Christopher Whitten returned 12,788,712 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Visioli Christopher returned 21,250 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- INSIDEREXECUTIVE CHAIRMAN Meanwell Clive returned 12,772,837 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- SECSEC Form S-8 POS filed by Metsera Inc.S-8 POS - Metsera, Inc. (0002040807) (Filer)
- SECMetsera Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Leadership Update8-K - Metsera, Inc. (0002040807) (Filer)
- SECSEC Form 25-NSE filed by Metsera Inc.25-NSE - Metsera, Inc. (0002040807) (Subject)
- PRPfizer Completes Acquisition of MetseraAcquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape Complements and transforms Pfizer's Internal Medicine portfolio Positions Pfizer to lead in one of the most dynamic and high-growth therapeutic areas Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ:MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases. "This strategic milestone represents more than a transaction—it's a deliberate investment in the future of medicine. By acquiring Metsera, we are directing our resou
- SECSEC Form 10-Q filed by Metsera Inc.10-Q - Metsera, Inc. (0002040807) (Filer)
- INSIDERSee Remark 1 Fmr Llc gifted 860,722 shares (SEC Form 4)4 - Metsera, Inc. (0002040807) (Issuer)
- SECSEC Form DEFA14A filed by Metsera Inc.DEFA14A - Metsera, Inc. (0002040807) (Filer)